Intuitive Dominates U.S. Laparoscopic Stapler Market with Over 51% Share as Robot-Assisted Surgery Reshapes Industry

Reported at the beginning of the yearIntuitive's laparoscopic stapler SureForm sales surpassed Johnson & Johnson and Medtronic last year, ranking first in the U.S. (For details, seeSureForm: Endoscopic Stapler Sales Outperform Johnson & Johnson and Medtronic | Tops in the U.S.）。

According to overseas statistics, in the past 18 months,Intuitive further consolidates its position inMarket Monopoly Position of Endoscopic Staplers. CurrentlyIntuitiveThe market share of the laparoscopic stapler SureForm exceeds 51%, surpassing the combined total of Medtronic and Johnson & Johnson.(The data for robot-assisted and laparoscopic surgeries are combined here).

This is a significant shift in the field of staplers. Data shows that the majority of revenue from endoscopic staplers currently comes from robotic surgery platforms, where the usage of robot-assisted endoscopic staplers has reached an estimated 43% of the total volume—a figure that is quite astonishing!

Currently, Medtronic's Hugo has received FDA approval for market release, which can reverse the declining trend of endoscopic staplers. Hugo provides a platform foundation for its endoscopic stapler Signia, with the potential to curb the shift in stapler business.IntuitiveThe trend of loss. Johnson & Johnson doesn't have the same opportunity as Medtronic, whose surgical robot...Ottava is still in the clinical stage, and it will take several more years to reach the market. Fortunately, Johnson & Johnson has not continued to slack off recently.ProclamationClothETHICON 4000 Integrated intoottava In China。

Currently, Medtronic and Johnson & Johnson are under significant pressure in the general surgery field.Hugo andOttava Becomes the Key to Turning Around for Two Companies.

The above statistics do not include companies such as Teleflex, RevMedica, and Lexington Medical, which are introducing innovative technologies that may be compatible with robotic platforms or focus on handheld devices, including advancements like low-resistance intelligent stapling for bariatric surgery.

The current market situation clearly sends out a signal: "To establish a foothold in the robotic surgery field, you must have a stapler product!"

This also sounds an alarm for a group of China's stapler companies. Soft tissue surgical robots in China are developing rapidly, and companies like MedBot have either launched or are developing staplers compatible with various surgical robots, which will bring significant changes to the domestic stapler market. If China's staplers fail to keep up with the trend of surgical robots, they may be directly phased out.